This test is most useful if any of these apply to you.
If you've had a serious reaction to a stinging insect and the lab work came back positive for both wasp and bee venom, you're left with a hard question: which one actually caused it? That answer matters because the wrong identification leads to the wrong shot regimen if you pursue venom immunotherapy.
This test measures IgE (immunoglobulin E) antibodies your body makes against Pol d 5, a single signature protein found in paper wasp venom. It's a precision tool that helps tell paper wasp allergy apart from yellow jacket allergy, honeybee allergy, and false signals from cross-reactive sugars on other insect proteins.
Pol d 5 (the technical name for paper wasp antigen 5) is one of the major venom proteins from Polistes dominula, the European paper wasp now widespread across the United States. When your immune system gets sensitized to paper wasp venom, it can produce antibodies that lock onto Pol d 5 specifically. Detecting those antibodies in your blood is a strong sign your body recognizes paper wasp venom as a threat.
This is a component test, meaning it looks at one purified protein rather than the whole venom soup. Conventional venom tests use crude extract, which contains many proteins plus sugar chains that other insects (and even ticks) share. Those shared parts can make a standard test light up even when paper wasps are not the real culprit. Pol d 5 testing skips that noise.
Venom immunotherapy involves a years-long series of injections of the venom you're allergic to. It works, but only if you get the right venom. People who test positive on whole-venom extracts for both yellow jacket and paper wasp face a real dilemma: are they allergic to both, or is one result an echo of the other?
In a study of vespid-allergic patients, combining antigen 5 (Pol d 5 and Ves v 5) with phospholipase components allowed clinicians to identify the most probable sensitizing species in the majority of cases. Without these components, that distinction wasn't possible. In Korean venom-allergic patients, Pol d 5 testing tracked closely with conventional paper wasp venom IgE testing and helped clarify the culprit species.
What this means for you: if you're weighing immunotherapy, knowing whether paper wasp venom is genuinely driving your allergy can spare you years of unnecessary injections to a venom you don't actually react to.
Sometimes a person has a clearly allergic reaction to a sting, but the standard venom test comes back borderline or negative. Adding Pol d 5 closes that gap. In Japanese patients suspected of hornet and paper wasp allergy, spiking conventional venom tests with recombinant Pol d 5 and Ves v 5 raised the overall sensitivity of venom-specific IgE testing. Several patients who had tested negative on conventional venom IgE became positive once the component was added.
If your sting history strongly suggests allergy but your basic labs don't agree, component testing is one of the clearest ways to resolve the mismatch.
A detectable level of Pol d 5 IgE means you are sensitized to paper wasp venom. Combined with a clinical history of a systemic reaction, this strongly supports the diagnosis of paper wasp venom allergy. A negative result lowers the likelihood of clinically relevant sensitization but does not fully rule out a serious reaction.
Here's the part that surprises people: the size of the IgE number is not a reliable forecast of how severe a future sting reaction will be. Across multiple studies of venom allergy, including work specifically on Pol d 5 and Ves v 5, IgE levels did not correlate with the grade of anaphylaxis. People with low IgE have had severe reactions, and people with high IgE have had mild ones. The presence of antibodies matters more than the exact number.
This is not a contradiction; it's a feature of what the test does. Pol d 5 IgE is a sensitization marker, not a severity scale. It answers "is your immune system primed to react to paper wasp venom?" with high accuracy. It does not answer "how dramatic will the next reaction be?" because severity depends on factors beyond IgE alone, including mast cell behavior, baseline tryptase, and the dose of venom delivered. Treat the result as a yes/no signal about the culprit insect, not as a thermometer for future risk.
A single Pol d 5 IgE reading captures a moment in your immune system. Over years, that picture changes. In patients undergoing venom immunotherapy, IgE to vespid components including Pol d 5 declines significantly across three years of treatment, tracking the immune system's growing tolerance. If you start immunotherapy, retesting Pol d 5 IgE every year or two is a reasonable way to confirm the treatment is shifting your biology in the right direction.
For someone newly diagnosed, a baseline test followed by a repeat in 3 to 6 months if you're starting any intervention, and then yearly while you remain at risk, keeps you ahead of changes rather than reacting to them.
A positive Pol d 5 IgE result in someone with a real sting reaction history should prompt a conversation with an allergist about venom immunotherapy. Companion tests typically include IgE to Ves v 5 (yellow jacket antigen 5), Ves v 1 and Pol d 1 (phospholipases), and whole venom extracts. CCD inhibition testing can clarify confusing patterns. Basophil activation testing adds functional information in difficult multi-sensitized cases.
A positive result without any history of a systemic sting reaction usually does not warrant treatment. The combination of clinical history plus component sensitization, not the lab number alone, drives decisions. If your test is positive and your reaction was severe, baseline tryptase is also worth checking, since elevated tryptase or a clonal mast cell disorder can change the long-term plan.
Evidence-backed interventions that affect your Paper Wasp Venom (Pol d 5) IgE level
Paper Wasp Venom (Pol d 5) IgE is best interpreted alongside these tests.
Paper Wasp Venom (Pol d 5) IgE is included in these pre-built panels.